I-3-Indolepropionic Acid (IPA) CAS 830-96-6 Purity >99.5% (HPLC) Factory High Quality

Incazelo emfushane:

Igama Lekhemikhali: 3-Indolepropionic Acid (IPA)

I-CAS: 830-96-6

Ubumsulwa: >99.5% (HPLC)

Ukubukeka: Okumhlophe Okumhlophe kuya Kumpushana Ophuzi Okhanyayo noma Amakristalu

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi oholayo kanye nomphakeli we-3-Indolepropionic Acid (IPA) (CAS: 830-96-6) enekhwalithi ephezulu, ukukhiqizwa kwezentengiso.Wamukelekile eku-odeni.

Chemical Properties:

Igama Lekhemikhali	3-Indolepropionic Acid
Omqondofana	IPA;3-(1H-indol-3-yl) propanoic acid;3-(1H-indol-3-yl) -propionic acid;3-(3-Indolyl)propanoic acid;3-(3-Indolyl) propionic acid
Inombolo ye-CAS	830-96-6
Inombolo yeCAT	I-RF-PI1540
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C11H11NO2
Isisindo samangqamuzana	189.21
I-Solubility ku-Methanol	I-Faint Turbidity
Iphuzu elibilayo	82℃ (ukukhanya)
Ukuminyana	0.960 g/mL ku-20℃
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	I-Off-White to Light Yellow Powder noma Amakristalu
Ukuhlanzeka / Indlela Yokuhlaziya	>99.5% (HPLC)
I-Melting Point	130.0 ~ 136.0℃
Umswakama (ngu-Karl Fischer)	<0.50%
Ukungcola Okukodwa	<0.50%
Ukungcola Okuphelele	<0.50%
1 H NMR Spectrum	Ihambisana Nesakhiwo
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	Pharmaceutical Intermediates

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

I-FAQ:

Isicelo:

I-3-Indolepropionic Acid (IPA) (CAS: 830-96-6), Isabela ekulungiseleleni: Ama-Fluorescent analogues we-strigolactones;Ama-anti-tumor agents;I-Melanocortin receptors ligands;ama-immunosuppressive agents;ama-inhibitors we-hepatitis C;I-Histamine H4 receptor agonists;Abamelene nabamukeli be-NR2B/NMDA;Umphikisi we-CB1 wokwelapha ukukhuluphala;ama-antibacterial agents;Isivimbeli sokubopha i-TGF-β receptor.